Pfizer Newsroom

Pfizer Analyst Ratings

Benzinga19:45

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Futu NewsOct 11 20:33

Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $30

Futu NewsOct 11 20:31

Jefferies Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksOct 11 20:05

Pfizer's Leadership Stability and Activist Investor Watch: A Hold Rating Analysis

TipRanksOct 11 15:20

Guggenheim Adjusts Pfizer Price Target to $36 From $35, Maintains Buy Rating

MT NewswiresOct 8 19:57

CFRA Initiates Pfizer(PFE.US) With Hold Rating, Announces Target Price $31

Futu NewsOct 8 18:31

TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu NewsOct 8 10:31

Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 8 07:31

Pfizer Hold Rating: Balancing Valuation Concerns and Growth Challenges

TipRanksOct 8 07:07

J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30

Futu NewsOct 7 19:33

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $36

Futu NewsOct 7 19:31

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB)

TipRanksOct 7 15:32

Barclays Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Futu NewsOct 7 15:31

BMO Capital Adjusts Pfizer Price Target to $70 From $36

MT NewswiresOct 4 23:38

Pfizer Analyst Ratings

BenzingaOct 3 22:54

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaOct 3 22:54

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33

Futu NewsSep 27 20:32

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33

Futu NewsSep 27 15:33

Jefferies Remains a Buy on Pfizer (PFE)

TipRanksSep 27 15:07